← Open Payments lookup

PHNONIA ROJAS: Open Payments

NPI 1417284407 · GLEN BURNIE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,097 in 102 payments from 24 companies in 2025. Trend: 2023 $2,042 · 2024 $2,167 · 2025 $2,097

Food & beverage: $2,097
CompanyPaymentsAmount
Novo Nordisk Inc22$531
Lilly USA, LLC11$221
ABBVIE INC.12$211
PFIZER INC.9$142
Boehringer Ingelheim Pharmaceuticals, Inc.6$141
AstraZeneca Pharmaceuticals LP5$106
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$97
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$89
Dexcom, Inc.5$87
Merck Sharp & Dohme LLC3$70

Products named: Rybelsus, MOUNJARO, JARDIANCE, VRAYLAR, Wegovy, CAPLYTA, XIFAXAN, Dexcom G6 Transmitter.

Industry payments across MD — which companies pay providers there.